Repeat surgery of recurrent glioma for molecularly informed treatment in the age of precision oncology: A risk –benefit analysis
ConclusionSurgery for recurrent glioma provides relevant molecular diagnostic information with a direct consequence for targeted therapy under a reasonable risk of postoperative complications. With satisfactory postoperative survival it can therefore complement a multi-modal glioma therapy approach.
Source: Journal of Neuro-Oncology - Category: Cancer & Oncology Source Type: research
More News: Astrocytoma | Brain | Brain Tumor | Cancer & Oncology | Craniotomy | Glioma | Neurology | Neurosurgery